News and Trends 10 Jul 2015
Sanofi to solve Growing Resistance against Malarial Treatments
Sanofi extended its collaboration with Medicines for Malaria Venture (MMV) to jointly develop a new combination therapy against malaria, the deadliest parasitic disease worldwide. The difficult access and the fear of a growing resistance to the existing treatments highlight the importance of this partnership. Atemisinin-based combination therapies (ACT) are at this moment the most efficient […]
